Since hsCRP is a general marker of inflammation, and specifically a marker of disease activity in RA and other inflammatory diseases, seeing an effect in healthy subjects is encouraging and consistent with PF-06650833 having a pharmacologic effect downstream in the TLR signaling cascade (and likely upstream of IL-6). Here, IL6 is linked to rheumatoid arthritis.